Cicor Technologies Reports Strong Order Intake Amid Challenges

On October 15, 2025, Cicor Technologies Ltd announced an impressive performance in the third quarter of 2025 despite a challenging environment. The company recorded a 33% rise in quarterly sales, reaching CHF 160.1 million, with a year-to-date increase of 25.4% totaling CHF 440.8 million. This growth is supported by a robust order intake of CHF 174.5 million, resulting in a book-to-bill ratio of 1.09.

Despite a slight decline in the Advanced Substrates division, attributed to reduced inventories by specific medical sector customers and the closure of an Ulm site, Cicor's Electronic Manufacturing Services (EMS) division achieved organic growth. The EMS division's performance defied the European EMS market's trend, which recorded an 8.1% decrease in the first half of 2025. New orders, especially in the aerospace and defense sector, are anticipated to bolster growth further in the final quarter.